Skip to content

Antisera to Human ALPHA1-ANTITRYPSIN

by Dade Behring, Inc. 510(k)

Active United States

510(k) K053072

Overview

This device is an antiserum used for the quantitative determination of human alpha1-antitrypsin in clinical samples. As classified under the nomenclature for immunology reagents, it functions as an antigen-specific antibody reagent, enabling precise measurement of alpha1-antitrypsin levels via immunonephelometry—a turbidimetric immunoassay technique.

Supplied as a reagent for in vitro diagnostic use, this product is intended for laboratory settings where serum or plasma samples are analyzed. It is not sterile and is designed for single-use per batch, adhering to regulatory standards outlined in 21 CFR 866.5130. The device holds a 510(k) clearance (K053072) under the FDA’s Traditional pathway, with no third-party distribution flag. Storage and handling must comply with manufacturer guidelines to maintain assay integrity.

AI-generated from registry data, 20 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK053072 Date28 Mar 2006ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 6 Oct 2026.

Specification

510(k)

Full name
N Antisera to Human ALPHA1-Antitrypsin
510(k) Number
FDA Product Code
DEM
Device Class
Class II
Regulation
21 CFR Part 866.5130
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Other devices from Dade Behring, Inc.

See all devices from Dade Behring, Inc. →

Questions

  • What is the primary use of the N Antiserum to Human Alpha1-Antitrypsin in a clinical setting?

    This antiserum is designed for the quantitative measurement of human alpha1-antitrypsin levels in serum or plasma samples. It functions as an antigen-specific antibody reagent within an immunonephelometry assay, enabling precise turbidimetric immunoassay results for laboratory diagnostics.

  • Is this product sterile, and how should it be handled to maintain its integrity?

    The N Antiserum to Human Alpha1-Antitrypsin is not sterile and is intended for single-use per batch. To preserve assay accuracy, storage and handling must strictly follow the manufacturer’s guidelines, as outlined in 21 CFR 866.5130.

  • Can this reagent be reused, or is it intended for single-use only?

    This product is explicitly designed for single-use per batch, meaning each batch should not be reused after opening or initial use. This aligns with regulatory standards to ensure consistent and reliable assay performance.

  • What type of regulatory clearance does this device hold, and how was it classified?

    The N Antiserum to Human Alpha1-Antitrypsin holds a 510(k) clearance (K053072) under the FDA’s Traditional pathway, classified as substantially equivalent under the nomenclature for immunology reagents. It was reviewed by the Immunology (IM) Advisory Committee and falls under product code DEM.

  • Where is this product manufactured, and how should it be stored?

    The product is manufactured by Dade Behring, Inc., based in Newark, DE. While the exact storage instructions are manufacturer-specific, compliance with their guidelines is critical to maintain assay integrity, as improper handling could compromise the reagent’s performance.